Please enable JavaScript to continue using this application.

Compare $CRDF vs $CTOR | Chartloom

Compare

$CRDF vs $CTOR

Cardiff Oncology Inc · Citius Oncology Inc

CRDF

Cardiff Oncology Inc

CTOR

Citius Oncology Inc

Compare $CRDF vs $CTOR

Comparing Cardiff Oncology Inc and Citius Oncology Inc

CRDFCardiff Oncology Inc

CTORCitius Oncology Inc

CRDFCardiff Oncology Inc

Market cap

$84M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

244.08x

Rev growth (TTM)

-7.0%

YTD performance

-59.4%

52W performance

-54.6%

FCF yield

-48.7%

CTORCitius Oncology Inc

Market cap

$78M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.10x

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-54.4%

FCF yield

-24.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRDF

CTOR

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

CTOR

Citius Oncology Inc

Market Cap

CRDF$84M

CTOR$78M

Enterprise Value

CRDF$75M

CTOR$72M

Price

CRDF$1.08

CTOR$0.84

P/E Ratio

CRDFN/A

CTORN/A

P/S Ratio

CRDF165.40x

CTOR10.99x

EV/Sales

CRDF147.30x

CTOR10.10x

EV/EBITDA

CRDF0.00x

CTOR0.00x

P/B Ratio

CRDF3.28x

CTOR2.19x

P/FCF Ratio

CRDFN/A

CTORN/A

EV/FCF

CRDF-1.83x

CTOR-3.70x

PEG Ratio

CRDFN/A

CTORN/A

Forward P/E (NTM)

CRDFN/A

CTORN/A

Forward P/S (NTM)

CRDF244.08x

CTOR1.10x

Revenue (TTM)

CRDF$508K

CTOR$7M

Revenue Growth (YoY)

CRDF-7.0%

CTORN/A

Forward Rev Growth

CRDF-19.6%

CTOR65.4%

Gross Margin (TTM)

CRDF100.0%

CTOR77.3%

Operating Margin (TTM)

CRDF0.0%

CTOR0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

CTOR-542.8%

Net Margin (TTM)

CRDF-7889.0%

CTOR-648.3%

FCF Margin (TTM)

CRDF-8054.3%

CTOR-272.9%

Net Income (TTM)

CRDF$-40M

CTOR$-46M

FCF (TTM)

CRDF$-41M

CTOR$-19M

EPS (TTM)

CRDF-$0.59

CTOR-$0.43

ROE (TTM)

CRDF-10308.0%

CTOR-10298.0%

ROA (TTM)

CRDF-7551.0%

CTOR-4349.0%

ROIC (TTM)

CRDF-10308.0%

CTOR-9188.0%

Cash

CRDF$9M

CTOR$17M

Debt

CRDF$0

CTOR$10M

Net Cash/Debt

CRDF$9M

CTOR$6M

Current Ratio (TTM)

CRDF3.30x

CTOR0.73x

Quick Ratio (TTM)

CRDF3.21x

CTOR0.29x

Debt/Equity (TTM)

CRDF0.00x

CTOR0.25x

Debt/Assets (TTM)

CRDF0.0%

CTOR0.0%

Interest Coverage (TTM)

CRDFN/A

CTORN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

CTOR0.00x

Beta

CRDF1.49

CTOR3.34

52W Performance

CRDF-54.6%

CTOR-54.4%

YTD Performance

CRDF-59.4%

CTOR-22.2%

% from 52W High

CRDF-67.4%

CTOR-62.7%

% from 52W Low

CRDF42.7%

CTOR71.0%

Asset Turnover (TTM)

CRDF0.01x

CTOR0.00x

FCF Yield (TTM)

CRDF-48.7%

CTOR-24.8%

Earnings Yield (TTM)

CRDF-47.7%

CTOR-59.0%

Dividend Yield (TTM)

CRDFN/A

CTORN/A

Rule of 40

CRDF-8,061.3

CTOR-272.9

EV/GP/RG

CRDFN/A

CTOR0.01

Ticker research

View CRDF research View CTOR research

Metric	CRDF Cardiff Oncology Inc	CTOR Citius Oncology Inc
Market & Valuation
Market Cap	$84M	$78M
Enterprise Value	$75M	$72M
Price	$1.08	$0.84
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	10.99x
EV/Sales	147.30x	10.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-3.70x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	1.10x
Revenue & Growth
Revenue (TTM)	$508K	$7M
Revenue Growth (YoY)	-7.0%	N/A
Forward Rev Growth	-19.6%	65.4%
Profitability
Gross Margin (TTM)	100.0%	77.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	-542.8%
Net Margin (TTM)	-7889.0%	-648.3%
FCF Margin (TTM)	-8054.3%	-272.9%
Net Income (TTM)	$-40M	$-46M
FCF (TTM)	$-41M	$-19M
EPS (TTM)	-$0.59	-$0.43
ROE (TTM)	-10308.0%	-10298.0%
ROA (TTM)	-7551.0%	-4349.0%
ROIC (TTM)	-10308.0%	-9188.0%
Financial Health
Cash	$9M	$17M
Debt	$0	$10M
Net Cash/Debt	$9M	$6M
Current Ratio (TTM)	3.30x	0.73x
Quick Ratio (TTM)	3.21x	0.29x
Debt/Equity (TTM)	0.00x	0.25x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	3.34
52W Performance	-54.6%	-54.4%
YTD Performance	-59.4%	-22.2%
% from 52W High	-67.4%	-62.7%
% from 52W Low	42.7%	71.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-48.7%	-24.8%
Earnings Yield (TTM)	-47.7%	-59.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	-272.9
EV/GP/RG	N/A	0.01
Ticker research	View CRDF research	View CTOR research

Valuation

P/S Ratio

CTOR

10.99x

CRDF

165.40x

EV/FCF

CTOR

-3.70x

CRDF

-1.83x

Growth & revenue

Revenue Growth TTM

CRDF

-7.0%

Forward Revenue Growth

CTOR

65.4%

CRDF

-19.6%

Profitability & performance

Gross Margin

CRDF

100.0%

CTOR

77.3%

ROE

CTOR

-10298.0%

CRDF

-10308.0%

FCF Yield %

CTOR

-24.8%

CRDF

-48.7%

52-Week Performance

CTOR

-54.4%

CRDF

-54.6%

Detailed metrics comparison

CRDF

Cardiff Oncology Inc

CTOR

Citius Oncology Inc

Market Cap

CRDF$84M

CTOR$78M

Enterprise Value

CRDF$75M

CTOR$72M

Price

CRDF$1.08

CTOR$0.84

P/E Ratio

CRDFN/A

CTORN/A

P/S Ratio

CRDF165.40x

CTOR10.99x

EV/Sales

CRDF147.30x

CTOR10.10x

EV/EBITDA

CRDF0.00x

CTOR0.00x

P/B Ratio

CRDF3.28x

CTOR2.19x

P/FCF Ratio

CRDFN/A

CTORN/A

EV/FCF

CRDF-1.83x

CTOR-3.70x

PEG Ratio

CRDFN/A

CTORN/A

Forward P/E (NTM)

CRDFN/A

CTORN/A

Forward P/S (NTM)

CRDF244.08x

CTOR1.10x

Revenue (TTM)

CRDF$508K

CTOR$7M

Revenue Growth (YoY)

CRDF-7.0%

CTORN/A

Forward Rev Growth

CRDF-19.6%

CTOR65.4%

Gross Margin (TTM)

CRDF100.0%

CTOR77.3%

Operating Margin (TTM)

CRDF0.0%

CTOR0.0%

EBITDA Margin (TTM)

CRDF-8251.0%

CTOR-542.8%

Net Margin (TTM)

CRDF-7889.0%

CTOR-648.3%

FCF Margin (TTM)

CRDF-8054.3%

CTOR-272.9%

Net Income (TTM)

CRDF$-40M

CTOR$-46M

FCF (TTM)

CRDF$-41M

CTOR$-19M

EPS (TTM)

CRDF-$0.59

CTOR-$0.43

ROE (TTM)

CRDF-10308.0%

CTOR-10298.0%

ROA (TTM)

CRDF-7551.0%

CTOR-4349.0%

ROIC (TTM)

CRDF-10308.0%

CTOR-9188.0%

Cash

CRDF$9M

CTOR$17M

Debt

CRDF$0

CTOR$10M

Net Cash/Debt

CRDF$9M

CTOR$6M

Current Ratio (TTM)

CRDF3.30x

CTOR0.73x

Quick Ratio (TTM)

CRDF3.21x

CTOR0.29x

Debt/Equity (TTM)

CRDF0.00x

CTOR0.25x

Debt/Assets (TTM)

CRDF0.0%

CTOR0.0%

Interest Coverage (TTM)

CRDFN/A

CTORN/A

Net Debt/EBITDA (TTM)

CRDF0.00x

CTOR0.00x

Beta

CRDF1.49

CTOR3.34

52W Performance

CRDF-54.6%

CTOR-54.4%

YTD Performance

CRDF-59.4%

CTOR-22.2%

% from 52W High

CRDF-67.4%

CTOR-62.7%

% from 52W Low

CRDF42.7%

CTOR71.0%

Asset Turnover (TTM)

CRDF0.01x

CTOR0.00x

FCF Yield (TTM)

CRDF-48.7%

CTOR-24.8%

Earnings Yield (TTM)

CRDF-47.7%

CTOR-59.0%

Dividend Yield (TTM)

CRDFN/A

CTORN/A

Rule of 40

CRDF-8,061.3

CTOR-272.9

EV/GP/RG

CRDFN/A

CTOR0.01

Ticker research

View CRDF research View CTOR research

Metric	CRDF Cardiff Oncology Inc	CTOR Citius Oncology Inc
Market & Valuation
Market Cap	$84M	$78M
Enterprise Value	$75M	$72M
Price	$1.08	$0.84
P/E Ratio	N/A	N/A
P/S Ratio	165.40x	10.99x
EV/Sales	147.30x	10.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.28x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.83x	-3.70x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	244.08x	1.10x
Revenue & Growth
Revenue (TTM)	$508K	$7M
Revenue Growth (YoY)	-7.0%	N/A
Forward Rev Growth	-19.6%	65.4%
Profitability
Gross Margin (TTM)	100.0%	77.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-8251.0%	-542.8%
Net Margin (TTM)	-7889.0%	-648.3%
FCF Margin (TTM)	-8054.3%	-272.9%
Net Income (TTM)	$-40M	$-46M
FCF (TTM)	$-41M	$-19M
EPS (TTM)	-$0.59	-$0.43
ROE (TTM)	-10308.0%	-10298.0%
ROA (TTM)	-7551.0%	-4349.0%
ROIC (TTM)	-10308.0%	-9188.0%
Financial Health
Cash	$9M	$17M
Debt	$0	$10M
Net Cash/Debt	$9M	$6M
Current Ratio (TTM)	3.30x	0.73x
Quick Ratio (TTM)	3.21x	0.29x
Debt/Equity (TTM)	0.00x	0.25x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.49	3.34
52W Performance	-54.6%	-54.4%
YTD Performance	-59.4%	-22.2%
% from 52W High	-67.4%	-62.7%
% from 52W Low	42.7%	71.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-48.7%	-24.8%
Earnings Yield (TTM)	-47.7%	-59.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,061.3	-272.9
EV/GP/RG	N/A	0.01
Ticker research	View CRDF research	View CTOR research